ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,133Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 335

$595K Total Retail Price of All Prescriptions

Rank: 14 out of 335

1,405 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 12,050 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

10 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
CARVEDILOL 1,338 1,129 1 1
SIMVASTATIN 925 811 2 4
WARFARIN SODIUM 778 713 3 8
AMLODIPINE BESYLATE 760 679 4 5
LISINOPRIL 725 590 5 2
METOPROLOL TARTRATE 671 557 6 3
FUROSEMIDE 501 406 7 6
HYDRALAZINE HCL 494 420 8 26
ATORVASTATIN CALCIUM 483 432 9 11
CRESTOR 459 361 10 17
CLOPIDOGREL 411 316 11 7
DIGOXIN 330 277 12 14
NIASPAN 328 314 13 35
LOSARTAN POTASSIUM 324 279 14 16
PLAVIX 315 263 15 12
PRAVASTATIN SODIUM 288 255 16 13
ATENOLOL 228 191 17 15
LOVASTATIN 213 166 18 49
ENALAPRIL MALEATE 192 161 19 38
SOTALOL 162 160 20 24
HYDROCHLOROTHIAZIDE 151 135 21 19
POTASSIUM CHLORIDE 147 122 22 18
ISOSORBIDE MONONITRATE ER 141 105 23 10
LEVOTHYROXINE SODIUM 140 117 24 36
PANTOPRAZOLE SODIUM 138 123 25 48
KLOR-CON M20 134 133 26 39
METOPROLOL SUCCINATE 124 94 27 9
DIOVAN 122 122 28 28
BYSTOLIC 105 80 29 31
AMLODIPINE BESYLATE-BENAZEPRIL 96 96 30 62
NITROSTAT 95 72 31 22
LOVAZA 94 83 32 78
ZETIA 89 77 33 34
NIFEDIPINE ER 87 75 34 59
OMEPRAZOLE 81 73 35 29
DILTIAZEM 24HR ER 81 79 35 58
METFORMIN HCL 75 66 37 67
DILTIAZEM ER 68 58 38 56
NIFEDICAL XL 68 68 38 123
AMIODARONE HCL 68 66 38 21
FAMOTIDINE 65 58 41 65
LIPITOR 64 35 42 40
RANEXA 63 52 43 25
RAMIPRIL 62 55 44 23
MINOXIDIL 59 59 45 117
NITROGLYCERIN PATCH 55 52 46 51
FLUDROCORTISONE ACETATE 51 47 47 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.